FHIT and urinary bladder cancer: BBN(N-butyl-N-(-4-hydroxybutyl)- nitrosamine)-induced urinary bladder cancer could be prevented in FHIT knock-out mouse by Rofecoxib, a cox-2 inhibitor [14].